BYL719

BYL719

CAT N°: 16986
Price:

From 80.00 68.00

BYL719 is an inhibitor of phosphoinositide 3-kinase ? (PI3K?; IC50s = 4.6, 4, and 4.8 nM for wild-type, E545K mutant, and H1047R mutant PI3K, respectively).{28003} It is selective for PI3K? over PI3K?, PI3K?, PI3K?, and PI4K? (IC50s = 1,156, 290, 250, and 581 nM, respectively), as well as VPS34, mTOR, DNA-PK, and ATR (IC50s = >9,100 nM for all). BYL719 (12.5, 25, and 50 mg/kg) reduces tumor volume in a PI3K?-dependent Rat1-myr-p110? mouse xenograft model. It also reduces tumor burden in THP-1 acute myeloid leukemia (AML) and MCF-7 breast cancer mouse xenograft models.{28001,28004} Formulations containing BYL719 have been used in the treatment of advanced or metastatic breast cancer.

We also advise you